IHH Annual Report 2023

Financial Statements Notes to the Financial Statements 11. DEFERRED TAX ASSETS AND LIABILITIES (continued) Unrecognised deferred tax assets Deferred tax assets have not been recognised in respect of the following items (stated at gross): Group 2023 2022 RM’000 RM’000 Deductible temporary difference 867,073 1,127,545 Unutilised tax losses 3,825,520 3,881,375 4,692,593 5,008,920 Deferred tax assets have not been recognised in respect of these items because it is not probable that future taxable profit will be available against which the respective subsidiaries can utilise the benefits therefrom. Tax losses are subject to agreement by the tax authorities and compliance with tax regulations in the countries in which the subsidiaries operate. The unutilised tax losses carried forward do not expire under current tax legislations, except for the amount of RM1,418,573,000 (2022: RM1,487,783,000) which will expire in the next 1 to 8 years. 12. DEVELOPMENT PROPERTIES Group 2023 2022 RM’000 RM’000 Medical suites 79,579 76,471 13. INVENTORIES Group 2023 2022 RM’000 RM’000 Pharmaceuticals, surgical and medical supplies 639,837 519,431 At 31 December 2023, there was floating charge over inventories with carrying amount of RM68,624,000 (2022: RM66,167,000) made to financial institutions as securities for credit facilities granted to certain subsidiaries. IHH Healthcare Berhad 174

RkJQdWJsaXNoZXIy NDgzMzc=